Of Bosses and Biotechs

Photo: Courtesy of Dennis McCoy Most entrepreneur-scientists who set out to start a company believe they can do it all. This hubris can lead to downfall. There is no substitute for the help of experienced business leadership. The managerial insights of the right partner are valuable. The confidence these partners give investors is essential. For the young, struggling Dyax of Cambridge, Mass., during the mid-1990s Henry Blair provided needed business and strategic leadership. He made Dyax a su

Written byDennis Mccoy
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Most entrepreneur-scientists who set out to start a company believe they can do it all. This hubris can lead to downfall. There is no substitute for the help of experienced business leadership. The managerial insights of the right partner are valuable. The confidence these partners give investors is essential.

For the young, struggling Dyax of Cambridge, Mass., during the mid-1990s Henry Blair provided needed business and strategic leadership. He made Dyax a success after others failed, because he understood the managerial and business nuances of building a biotechnology company, having founded Genzyme, GelTex, and other biotech companies. He knew that a business partner should have successful biotechnology experience and should understand how to build a biotech company.

"A lot of what I know about building a business I learned from my first business partner in Genzyme," says Blair, who worked in academia before launching that company. "His help was absolutely ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies